Preliminary investigation on the development of diltiazem resin complex loaded carboxymethyl xanthan beads

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 295-301

  Ray, Somasree ^a   Maiti, Sabyasachi ^b   Sa, Biswanath ^b  

^a GUPTA COLLEGE OF TECHNOLOGICAL SCIENCES   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Carboxymethyl xanthan beads; Diltiazem; Entrapment; Release; Resinate

Indexed keywords

ALUMINUM CHLORIDE; CARBOXYMETHYL XANTHAN; DILTIAZEM; UNCLASSIFIED DRUG; XANTHAN; CARBOXYMETHYL GUAR GUM; GALACTAN; MANNAN; MICROSPHERE; PLANT GUM; RESIN; VASODILATOR AGENT;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DIFFUSION; DRUG SOLUBILITY; DRUG STABILITY; GELATION; INTESTINE FLUID; PH; SCANNING ELECTRON MICROSCOPY; SIMULATION; STOMACH JUICE; SUSTAINED RELEASE FORMULATION; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG SCREENING; MATERIALS TESTING; PILOT STUDY;

DELAYED-ACTION PREPARATIONS; DIFFUSION; DILTIAZEM; DRUG EVALUATION, PRECLINICAL; GALACTANS; MANNANS; MATERIALS TESTING; MICROSPHERES; PILOT PROJECTS; PLANT GUMS; RESINS, SYNTHETIC; VASODILATOR AGENTS;

EID: 44849084189     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-007-9012-x     Document Type: Article

References (34)

1. M. R. Harris, and I. Ghebre-Sellassie. Aqueous Polymeric Coating for Modified Release Pellets. In J. W. McGinity (ed.), Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, Marcel Dekker Inc, New York, 1989, p. 64.
2. S. P. Vyas, and R. P. Khar. Controlled Drug Delivery Concepts and Advances, Delhi, Vallabh Prakashan, 2002, p. 102.
3. H. Tomida, C. Mizuo, C. Nakamura, and S. Kiryu. Imipramine release from Ca-alginate gel beads. Chem. Pharm. Bull. 41:1475-1477 (1993).
4. S. Shiraishi, T. Imai, and M. Otagiri. Controlled-release preparation of indomethacin using calcium alginate gel. Biol. Pharm. Bull. 16:1164-1168 (1993).
5. K. Tatesnita, S. Sugawara, T. Imai, and M. Otagiri. Preparation and evaluation of a controlled release formulation of nifedipine using calcium alginate beads. Biol. Pharm. Bull. 16:420-424 (1993).
6. P. R. Hari, T. Chandy, and C. P. Sharma. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencap. 13:319-329 (1996).
7. L. Y. Lim, and S. C. L. Wan. Propranolol hydrochloride binding in calcium alginate beads. Drug Dev. Ind. Pharm. 23:973-980 (1997).
8. P. Aslani, and R. A. Kennedy. Studies on diffusion in alginate gels. I. Effect of cross-linking with calcium or zinc ions on diffusion of acetaminophen. J. Control. Rel. 42:75-82 (1996).
9. B. J. Lee, G. H. Min, and J. H. Cui. Correlation of drug solubility with trapping efficiency and release characteristics of alginate beads. Pharm. Pharmacol. Commun. 5:85-89 (1999).
10. L. S. Liu, S. G. Liu, S. Y. Ng, N. Froix, T. Ohno, and J. Heller. Controlled release of interleukin-2 for tumor immunotherapy using alginate/chitosan porous microspheres. J. Control. Rel. 43:65-74 (1997).
11. T. Yotsuyanagi, T. Ohkubo, T. Ohhashi, and K. Ikeda. Calcium induced gelation of alginic acid and pH-sensitive reswelling of dried gels. Chem. Pharm. Bull. 35:1555-1563 (1987).
12. M. L. González Rodríguez, M. A. Holgado, C. Sánchez-Lafuente, A. M. Rabasco, and A. Fini. Alginate/chitosan particulate systems for sodium diclofenac release. Int. J. Pharm. 232:225-234 (2002).
13. H. Tomida, C. Mizuo, C. Nakamura, and S. Kiryu. Imipramine release from Ca-alginate gel beads. Chem. Pharm. Bull. 41:1475-1477 (1993).
14. A. Halder, S. Mukherjee, and B. Sa. Development and evaluation of polyethyleneimine-treated calcium alginate beads for sustained release of diltiazem. J. Microencap. 22(1):67-80 (2005).
15. A. Halder, S. Maiti, and B. Sa. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex. Int. J. Pharm. 302:84-94 (2005).
16. K. S. Kang, and D. J. Pettitt. Xanthan, Gellan, Welan and Rhamsan. In R. L. Whistler, and J. N. BeMiller (eds.), Industrial Gums, Polysaccharides and Their Derivatives, Academic, New York, 1993, pp. 343-393.
17. B. Katzbauer. Properties and applications of xanthan gum. Polym. Degrad. Stabil. 59:81-84 (1998).
18. G. Bumphrey. Extremely useful new suspending agent. Pharm. J. 237:665-671 (1986).
19. M. M. Talukdar, and J. Plaizier-Vercammen. Evaluation of xanthan gum as hydrophilic matrix for controlled release dosage form preparations. Drug. Dev. Ind. Pharm. 19:1037-1046 (1993).
20. M. M. Talukdar, A. Michoel, P. Rombaut, and R. Kinget. Comparative study on xanthan gum and hydroxypropyl methylcellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behaviour. Int. J. Pharm. 129:233-241 (1996a).
21. Z. Yang, B. Song, Q. Li, H. Fan, and F. Ouyang. Preparation of microspheres with microballoons inside for floating drug delivery systems. J. Appl. Polym. Sci. 94:197-202 (2004).
22. C. H. Chu, H. Kumagai, and K. Nakamura. Application of polyelectrolyte complex gel composed of xanthan and chitosan to the immobilization of Corynebacterium glutamicum. J. Appl. Polym. Sci. 60:1041-1047 (1996).
23. S. Dumitriu and E. Chornet. Immobilization of xylanase in chitosan-xanthan hydrogels. Biotechnol. Prog. 13:539-545 (1997).
24. B. Sa and C. M. Setty. Indian Patent Application No 00578/KOL/ 2004(23.9.04).
25. E. R. Barnhart. Physicians' Deck Reference, 45th edn, Medical Economics Co. Inc., Oradell, NJ, 1991, pp. 1293.
26. L. S. Goodman and A. Gilman. The Pharmacological Basis of Therapeutics, 7th edn, Macmillan Publishing Company, New York, 1985.
27. M. Chaffman and R. N. Brogden. Diltiazem, a review of its pharmacological properties and therapeutic efficacy. Drugs 29:387-454 (1985).
28. D. J. Maxxo, C. L. Obetz, and J. Shuster. Diltiazem hydrochloride. In H. Brittain (eds.), Analytical Profiles of Drug Substances and Excipients, Academic Press, New York, 1994, 23, pp. 53-98.
29. W. J. Irwin, K. A. Belaid, and H. O. Alpar. Drug delivery by ion exchange. Part III. Interaction of ester prodrugs of propranolol with cationic exchange resins. Drug Dev. Ind. Pharm. 13:2047-2066 (1987).
30. R. W. Korsmeyer, R. Gurny, E. Docler, P. Buri, and N. A. Peppas. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 15:25-35 (1983).
31. P. Sriamornsak, and S. Sungthongjeen. Modification of theophylline Rrelease with alginate gel formed in hard capsules. AAPS:8(3):article51 (2007).
32. C. M. Setty. Development and Evaluation of Novel Microparticulate Drug Delivery System Using Natural Polymer [Ph.D Thesis] Kolkata: Jadavpur University, 2005.
33. A. H. El-Kamel, O. M. N. Al-gohary, and E. A. Hosny. Alginate-diltiazem hydrochloride beads: Optimization of formulation factors, in vitro and in vivo bioavailability. J. Microencap. 20:211-225 (2003).
34. M. Turkoglu, A. Gursay, L. Eroglu, and I. Okar. Effect of aqueous polymer dispersions on properties of diclofenac alginate beads and in vitro evaluation in rats. STP Pharm. Sci. 7:135-140 (1997).